Objectivity in research in the pharmaceutical industry is possible

A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research pr...

Full description

Saved in:
Bibliographic Details
Published in:Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen Fortbildung und Qualität im Gesundheitswesen, 2010, Vol.104 (3), p.177
Main Authors: Torfs, Koen, Rudolph, Ina, Mehnert, Angelika, Sindern, Jörn
Format: Article
Language:ger
Subjects:
Clinical Trials as Topic - standards
Drug Industry - ethics
Drug Industry - standards
Drug Therapy - standards
Ethics, Research
Germany
Humans
Publishing - standards
Research - standards
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 3
container_start_page 177
container_title Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
container_volume 104
creator Torfs, Koen
Rudolph, Ina
Mehnert, Angelika
Sindern, Jörn
description A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research projects conducted by the pharmaceutical industry. Problems with meeting objectivity criteria on the part of the pharmaceutical industry will be highlighted, distinguishing between industrial research activities themselves (i.e., studies) and the publication of data resulting from such research. The aim of the discussion is to illustrate how and which research-guiding conditions can ensure that sponsors indeed meet the criteria for objective research.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_20608244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20608244</sourcerecordid><originalsourceid>FETCH-pubmed_primary_206082443</originalsourceid><addsrcrecordid>eNpjYeA0tDAz1bU0MjTnYOAqLs4yMDAzMjYzZWfgMDIwM7AwMjHhZHDyT8pKTS7JLMssqVTIzFMoSi1OTSxKzgCxSzJSFQoyEotyE5NTS0sykxNzgKIppcUlRUClxQoF-cXFmUk5qTwMrGmJOcWpvFCam0HOzTXE2UO3oDQpNzUlvqAoMzexqDIeZqkxQQUAeck3uQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Objectivity in research in the pharmaceutical industry is possible</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Torfs, Koen ; Rudolph, Ina ; Mehnert, Angelika ; Sindern, Jörn</creator><creatorcontrib>Torfs, Koen ; Rudolph, Ina ; Mehnert, Angelika ; Sindern, Jörn</creatorcontrib><description>A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research projects conducted by the pharmaceutical industry. Problems with meeting objectivity criteria on the part of the pharmaceutical industry will be highlighted, distinguishing between industrial research activities themselves (i.e., studies) and the publication of data resulting from such research. The aim of the discussion is to illustrate how and which research-guiding conditions can ensure that sponsors indeed meet the criteria for objective research.</description><identifier>ISSN: 1865-9217</identifier><identifier>PMID: 20608244</identifier><language>ger</language><publisher>Netherlands</publisher><subject>Clinical Trials as Topic - standards ; Drug Industry - ethics ; Drug Industry - standards ; Drug Therapy - standards ; Ethics, Research ; Germany ; Humans ; Publishing - standards ; Research - standards</subject><ispartof>Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2010, Vol.104 (3), p.177</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4023</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20608244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Torfs, Koen</creatorcontrib><creatorcontrib>Rudolph, Ina</creatorcontrib><creatorcontrib>Mehnert, Angelika</creatorcontrib><creatorcontrib>Sindern, Jörn</creatorcontrib><title>Objectivity in research in the pharmaceutical industry is possible</title><title>Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen</title><addtitle>Z Evid Fortbild Qual Gesundhwes</addtitle><description>A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research projects conducted by the pharmaceutical industry. Problems with meeting objectivity criteria on the part of the pharmaceutical industry will be highlighted, distinguishing between industrial research activities themselves (i.e., studies) and the publication of data resulting from such research. The aim of the discussion is to illustrate how and which research-guiding conditions can ensure that sponsors indeed meet the criteria for objective research.</description><subject>Clinical Trials as Topic - standards</subject><subject>Drug Industry - ethics</subject><subject>Drug Industry - standards</subject><subject>Drug Therapy - standards</subject><subject>Ethics, Research</subject><subject>Germany</subject><subject>Humans</subject><subject>Publishing - standards</subject><subject>Research - standards</subject><issn>1865-9217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0tDAz1bU0MjTnYOAqLs4yMDAzMjYzZWfgMDIwM7AwMjHhZHDyT8pKTS7JLMssqVTIzFMoSi1OTSxKzgCxSzJSFQoyEotyE5NTS0sykxNzgKIppcUlRUClxQoF-cXFmUk5qTwMrGmJOcWpvFCam0HOzTXE2UO3oDQpNzUlvqAoMzexqDIeZqkxQQUAeck3uQ</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Torfs, Koen</creator><creator>Rudolph, Ina</creator><creator>Mehnert, Angelika</creator><creator>Sindern, Jörn</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>2010</creationdate><title>Objectivity in research in the pharmaceutical industry is possible</title><author>Torfs, Koen ; Rudolph, Ina ; Mehnert, Angelika ; Sindern, Jörn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_206082443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2010</creationdate><topic>Clinical Trials as Topic - standards</topic><topic>Drug Industry - ethics</topic><topic>Drug Industry - standards</topic><topic>Drug Therapy - standards</topic><topic>Ethics, Research</topic><topic>Germany</topic><topic>Humans</topic><topic>Publishing - standards</topic><topic>Research - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torfs, Koen</creatorcontrib><creatorcontrib>Rudolph, Ina</creatorcontrib><creatorcontrib>Mehnert, Angelika</creatorcontrib><creatorcontrib>Sindern, Jörn</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torfs, Koen</au><au>Rudolph, Ina</au><au>Mehnert, Angelika</au><au>Sindern, Jörn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Objectivity in research in the pharmaceutical industry is possible</atitle><jtitle>Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen</jtitle><addtitle>Z Evid Fortbild Qual Gesundhwes</addtitle><date>2010</date><risdate>2010</risdate><volume>104</volume><issue>3</issue><spage>177</spage><pages>177-</pages><issn>1865-9217</issn><abstract>A number of publications on publication bias or selected outcomes reporting have led critics to doubt that the pharmaceutical industry is able to remain objective in its research activities. This paper discusses the prerequisites for objective research and to what extent these are met by research projects conducted by the pharmaceutical industry. Problems with meeting objectivity criteria on the part of the pharmaceutical industry will be highlighted, distinguishing between industrial research activities themselves (i.e., studies) and the publication of data resulting from such research. The aim of the discussion is to illustrate how and which research-guiding conditions can ensure that sponsors indeed meet the criteria for objective research.</abstract><cop>Netherlands</cop><pmid>20608244</pmid></addata></record>
fulltext fulltext
identifier ISSN: 1865-9217
ispartof Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2010, Vol.104 (3), p.177
issn 1865-9217
language ger
recordid cdi_pubmed_primary_20608244
source ScienceDirect Freedom Collection 2022-2024
subjects Clinical Trials as Topic - standards
Drug Industry - ethics
Drug Industry - standards
Drug Therapy - standards
Ethics, Research
Germany
Humans
Publishing - standards
Research - standards
title Objectivity in research in the pharmaceutical industry is possible
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A09%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Objectivity%20in%20research%20in%20the%20pharmaceutical%20industry%20is%20possible&rft.jtitle=Zeitschrift%20fu%CC%88r%20Evidenz,%20Fortbildung%20und%20Qualita%CC%88t%20im%20Gesundheitswesen&rft.au=Torfs,%20Koen&rft.date=2010&rft.volume=104&rft.issue=3&rft.spage=177&rft.pages=177-&rft.issn=1865-9217&rft_id=info:doi/&rft_dat=%3Cpubmed%3E20608244%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-pubmed_primary_206082443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/20608244&rfr_iscdi=true